Moreover, CD300A was capable of binding to tumor cells through interaction with phosphatidylserine (PS) in tumor cells, and blocking CD300A-PS interaction resulted in enhanced NK cell killing of tumor cell [24]. Here, CD300A is linked to neoplasm.